Original News Release
Rocket Doctor closes $4.23-million private placement
Dr. Essam Hamza reports
ROCKET DOCTOR AI INC ANNOUNCES CLOSING OF C$4.23M OVER-SUBSCRIBED NON-BROKERED PRIVATE PLACEMENT OF SPECIAL WARRANTS AND UNITS
Further to Rocket Doctor AI Inc.'s (formerly Treatment.com AI Inc.) news release dated July 25, 2025, it has closed its non-brokered private placement of 3,677,400 special warrants of the company at a price of 50 cents per special warrant, for aggregate gross proceeds of $1,838,700 and 4,792,000 units of the company at a price of 50 cents per unit, for aggregate gross proceeds of $2,396,000.
Dr. Essam Hamza, chief executive officer of Rocket Doctor AI, added: "We are appreciative of our investors for the very strong demand for this raise. These funds will help us unlock the next chapter at this critical inflection point for our company, especially enabling us to accelerate our U.S. expansion plans. We look forward to updating the shareholders and the market as we progress."
Each unit comprised one common share of the company and one share purchase warrant of the company, with each warrant exercisable into one share at an exercise price of 75 cents for 12 months from the date of issuance of the warrants.
Each special warrant will automatically convert, for no additional consideration, into one unit on the date that is the earlier of: (i) the third business day after the date of filing a prospectus supplement to a short-form base shelf prospectus qualifying the distribution of the shares and warrants issuable upon the conversion of the special warrants, and (ii) four months and one day after the issue date of the special warrants. No special warrants may be exercised by the holder thereof prior to the conversion date.
In connection with the offering, the company has paid finders' fees totalling $201,616 and issued an aggregate of 403,232 non-transferable broker warrants to arm's-length parties. Each broker warrant entitles the holder to purchase one share at an exercise price of 75 cents per share for a period of 12 months from the date of issuance of the broker warrants.
The company intends to use the proceeds from the offering for sales and administrative expenses, software research and development, and working capital purposes.
Prior to the filing of a prospectus supplement, the special warrants and the securities issuable upon conversion of the special warrants are subject to a statutory hold period of four months plus one day from the date of issuance in accordance with applicable securities legislation. The units issued today and the broker warrants, including the securities issuable thereunder, are subject to a statutory hold period of four months plus one day from the date of issuance in accordance with applicable securities legislation. The special warrants and warrants will not be listed on any stock exchange or over-the-counter market.
About Rocket Doctor AI Inc.
Rocket Doctor AI delivers physician-built, AI-powered solutions designed to make high-quality health care accessible throughout the entire patient journey. A corner-stone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide. Alongside the GLM is Rocket Doctor, and its AI-powered digital health platform and marketplace. Having helped empower over 300 MDs to provide care to more than 700,000 patient visits, the company's proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices -- improving efficiency, restoring autonomy to MDs and expanding patient access to care.
By reducing administrative burdens and ensuring greater consistency in care, the company's technology creates more time for meaningful physician-patient interactions. The company is committed to reaching underserved, rural and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models and connected medical devices, Rocket Doctor AI is redefining modern health care -- making it more scalable, equitable and patient centred.
We seek Safe Harbor.
View at source ↗